Company: MDCXW
Filing Date: 2025-09-29
Form Type: S-1
Source: 0001062993-25-015839
Chunk: 286

Company: Medicus Pharma Ltd.
Filing Date: 2025-09-29
Form: S-1
Chunk 286
---
.15       | Securities Purchase Agreement, by and between Medicus Pharma Ltd. and YA II PN, Ltd., dated September 17, 2025 (incorporated by reference from Exhibit 10.1 to the Registrant’s Current Report on Form 8-K, filed with the SEC on September 18, 2025).                            |
| 10.16       | Global Guaranty Agreement, by and among the subsidiaries of Medicus Pharma Ltd. set forth in Schedule I thereto, dated September 17, 2025 (incorporated by reference from Exhibit 10.2 to the Registrant’s Current Report on Form 8-K, filed with the SEC on September 18, 2025). |
| 21.1^       | List of Subsidiaries of Medicus Pharma Ltd.                                                                                                                                                                                                                                       |
| 23.1^       | Consent of EisnerAmper LLP                                                                                                                                                                                                                                                        |
| 23.2^       | Consent of MNP LLP                                                                                                                                                                                                                                                                |
| 23.3^       | Consent of Bennett Jones LLP (included in Exhibit 5.1)                                                                                                                                                                                                                            |
| 24.1^       | Powers of Attorney (included in the signature page to this Registration Statement)                                                                                                                                                                                                |
| 107^        | Filing fee table                                                                                                                                                                                                                                                                  |

^Filed herewith.

+Indicates a management contract or compensatory plan.

*Certain portions of this exhibit have been redacted pursuant to Item 601(b)(10)(iv) of Regulation S-K. The Company hereby undertakes to furnish supplementally copies of any of the omitted schedules upon request by the SEC.

#Schedules and certain other private or confidential information (as indicated therein) have been omitted pursuant to Item 601(b)(2) of Regulation S-K. The Company hereby undertakes to furnish supplementally copies of any of the omitted schedules upon request by the SEC.

† Certain private or confidential information (as indicated therein) have been redacted pursuant to Item 601(a)(6) of Regulation S-K.

<div align='center'>II-8

SIGNATURES</div>

Pursuant to the requirements of the Securities Act, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized in W. Conshohocken, Pennsylvania this 29 day of September, 2025.

| MEDICUS PHARMA LTD. |                                                       |
| By:                 | /s/